Pharmaleaf - Advancing Global Access

What we’re seeing across regulatory environments

Notes, observations, and perspectives from ongoing work.

In-House vs. Outsourced Regulatory Affairs: A Cost-Benefit Framework for Growing Biotechs

28 Aug, 26
5 min read

In-House vs. Outsourced Regulatory Affairs: A Cost-Benefit Framework for Growing Biotechs

Pharmacovigilance in the Age of AI: Automating Signal Detection Without Losing Compliance

22 Aug, 26
5 min read

Pharmacovigilance in the Age of AI: Automating Signal Detection Without Losing Compliance

Real-World Evidence (RWE) in Regulatory Submissions: How Sponsors Are Using It in 2026

15 Aug, 26
5 min read

Real-World Evidence (RWE) in Regulatory Submissions: How Sponsors Are Using It in 2026